Plasma microRNAs serve as potential biomarkers for abdominal aortic aneurysm

Clinical Biochemistry

Volumn 48, Issue 15, 2015, Pages 988-992

  Zhang, Wenwen ^a   Shang, Tao ^a   Huang, Chen ^a   Yu, Tong ^a   Liu, Chen ^a   Qiao, Tong ^a   Huang, Dian ^a   Liu, Zhao ^a   Liu, Changjian ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Abdominal aortic aneurysm; Biomarkers; MiRNAs

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 1282; MICRORNA 191 3P; MICRORNA 455 3P; UNCLASSIFIED DRUG; MIRN1281 MICRORNA, HUMAN; MIRN191 MICRORNA, HUMAN; MIRN455 MICRORNA, HUMAN;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VALIDATION STUDY; AORTIC ANEURYSM, ABDOMINAL; BLOOD; CASE CONTROL STUDY; CHEMISTRY; DNA MICROARRAY; MIDDLE AGED; MOLECULAR DIAGNOSIS; PLASMA; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; AORTIC ANEURYSM, ABDOMINAL; BIOMARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMA; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; SENSITIVITY AND SPECIFICITY; UP-REGULATION;

EID: 84943553960     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.04.016     Document Type: Article

References (22)

1. Nordon I.M., Hinchliffe R.J., Loftus I.M., Thompson M.M. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol 2011, 8:92-102.
2. Davis F.M., Rateri D.L., Daugherty A. Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies. Heart 2014.
3. Verhoeven E.L., Kapma M.R., Groen H., Tielliu I.F., Zeebregts C.J., Bekkema F., et al. Mortality of ruptured abdominal aortic aneurysm treated with open or endovascular repair. J Vasc Surg 2008, 48:1396-1400.
4. Svensjo S., Bjorck M., Wanhainen A. Update on screening for abdominal aortic aneurysm: a topical review. Eur J Vasc Endovasc Surg 2014, 48:659-667.
5. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
6. Engelhardt S. Small RNA biomarkers come of age. J Am Coll Cardiol 2012, 60:300-303.
7. Small E.M., Frost R.J., Olson E.N. MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010, 121:1022-1032.
8. Maegdefessel L., Spin J.M., Adam M., Raaz U., Toh R., Nakagami F., et al. Micromanaging abdominal aortic aneurysms. Int J Mol Sci 2013, 14:14374-14394.
9. Maegdefessel L., Azuma J., Toh R., Deng A., Merk D.R., Raiesdana A., et al. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Sci Transl Med 2012, 4(122):ra22.
10. Maegdefessel L., Azuma J., Toh R., Merk D.R., Deng A., Chin J.T., et al. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest 2012, 122:497-506.
11. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18:997-1006.
12. Maegdefessel L., Spin J.M., Raaz U., Eken S.M., Toh R., Azuma J., et al. Mir-24 limits aortic vascular inflammation and murine abdominal aneurysm development. Nat Commun 2014, 5:5214.
13. Zampetaki A., Attia R., Mayr U., Gomes R.S., Phinikaridou A., Yin X., et al. Role of mir-195 in aortic aneurysmal disease. Circ Res 2014, 115:857-866.
14. Adam M., Raaz U., Spin J.M., Tsao P.S. MicroRNAs in abdominal aortic aneurysm. Curr Vasc Pharmacol 2013.
15. Milewicz D.M. MicroRNAs, fibrotic remodeling, and aortic aneurysms. J Clin Invest 2012, 122:490-493.
16. Kim C.W., Kumar S., Son D.J., Jang I.H., Griendling K.K., Jo H. Prevention of abdominal aortic aneurysm by anti-microRNA-712 or anti-microRNA-205 in angiotensin II-infused mice. Arterioscler Thromb Vasc Biol 2014.
17. Spin J.M., Tsao P.S. Battle of the bulge: mir-195 versus mir-29b in aortic aneurysm. Circ Res 2014, 115:812-813.
18. Kin K., Miyagawa S., Fukushima S., Shirakawa Y., Torikai K., Shimamura K., et al. Tissue- and plasma-specific microRNA signatures for atherosclerotic abdominal aortic aneurysm. J Am Heart Assoc 2012, 1:e000745.
19. Pahl M.C., Derr K., Gabel G., Hinterseher I., Elmore J.R., Schworer C.M., et al. MicroRNA expression signature in human abdominal aortic aneurysms. BMC Med Genomics 2012, 5:25.
20. Biros E., Moran C.S., Wang Y., Walker P.J., Cardinal J., Golledge J. MicroRNA profiling in patients with abdominal aortic aneurysms: the significance of mir-155. Clin Sci (Lond.) 2014, 126(11):795-803.
21. Li S., Zhu J., Zhang W., Chen Y., Zhang K., Popescu L.M., et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 2011, 124:175-184.
22. Guay C., Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol 2013, 9:513-521.